CVS
CVS Health Corp
NYSE: CVS · HEALTHCARE · HEALTHCARE PLANS
$83.90
+3.61% today
Updated 2026-04-29
Market cap
$107.53B
P/E ratio
60.36
P/S ratio
0.27x
EPS (TTM)
$1.39
Dividend yield
3.28%
52W range
$56 – $84
Volume
7.7M
CVS Health Corp (CVS) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+21.3%
Last 4 quarters
Revenue YoY growth
+8.2%
Most recent quarter
EPS YoY growth
-8.4%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-1.6%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
-6.7%
2025-10-29
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-10 | $1.09 | +9.0% | $75.77 | $77.02 | +1.6% |
| 2025-10-29 | $1.60 | +17.6% | $82.20 | $76.69 | -6.7% |
| 2025-07-31 | $1.81 | +24.0% | $62.30 | $62.47 | +0.3% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $1.00 | $1.09 | +9.0% | $105.69B | +8.2% |
| 2025-09-30 | $1.36 | $1.60 | +17.6% | $102.87B | +7.8% |
| 2025-06-30 | $1.46 | $1.81 | +24.0% | $98.92B | +8.4% |
| 2025-03-31 | $1.67 | $2.25 | +34.7% | $94.59B | +7.0% |
| 2024-12-31 | $0.92 | $1.19 | +29.3% | $97.71B | +4.2% |
| 2024-09-30 | $1.46 | $1.09 | -25.3% | $95.43B | +6.3% |
| 2024-06-30 | $1.73 | $1.83 | +5.8% | $91.23B | +2.6% |
| 2024-03-31 | $1.70 | $1.31 | -22.9% | $88.44B | — |
| 2023-12-31 | $1.99 | $2.12 | +6.5% | $93.81B | — |
| 2023-09-30 | $2.13 | $2.21 | +3.8% | $89.76B | — |
| 2023-06-30 | $2.11 | $2.21 | +4.7% | $88.92B | — |
Analyst EPS and revenue estimates for upcoming years
| Period | EPS estimate | Revenue estimate | Revenue growth | Analysts | Confidence |
|---|---|---|---|---|---|
| 2026 (E) | $7.25 | $409.6B | +1.9% | 18 | high |
| 2027 (E) | $8.27 | $427.9B | +4.5% | 18 | high |
| 2028 (E) | $9.10 | $447.5B | +4.6% | 18 | medium |
| 2029 (E) | $9.95 | $468.2B | +4.6% | 18 | medium |
| 2030 (E) | $10.85 | $489.8B | +4.6% | 18 | medium |
Frequently asked questions
Has CVS Health Corp beaten earnings estimates?
CVS Health Corp has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +21.3% over the last 4 quarters.
How does CVS stock react to earnings?
CVS stock has moved an average of -1.6% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is CVS Health Corp's revenue growth rate?
CVS Health Corp reported year-over-year revenue growth of +8.2% in its most recent quarter, with EPS growing -8.4% year-over-year.
What is the expected EPS for CVS in 2026?
Analysts expect CVS Health Corp to report EPS of $7.25 for fiscal year 2026, on revenue of $409.6B, based on estimates from 18 analysts.